NCM · Medical - Devices

PAVM (PAVM) Stock

$5.25 +0.96% NCM: PAVM Healthcare

Valuation

MetricValue
Price$5.25
Market Cap$2.82M
P/E Ratio-1.08
P/B Ratio0.10
P/S Ratio0.15
EPS (TTM)$-5.63
52-Week High$28.44
52-Week Low$3.85
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE0.00%
ROA—
ROCE-100.00%
Gross Margin-3.41%
Operating Margin-364.93%
Net Margin-317.57%
Debt/Equity0.43
Current Ratio0.20

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0M$0$2.0M$3.0M$0
Operating Profit$-54.0M$-91.0M$-69.0M$-44.0M$-22.0M
Net Profit$-50.0M$-89.0M$-64.0M$40.0M$0
EPS$-293.92$-450.95$-274.92$14.88$-5.63
Op Margin-10878.6%-24161.0%-2805.7%-1485.4%-30712.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$87.0M$54.0M$33.0M$31.0M$39.0M
Total Liabilities$8.0M$43.0M$57.0M$38.0M$17.0M
Cash$77.0M$40.0M$20.0M$1.0M$2.0M
Borrowings$0$37.0M$49.0M$32.0M$13.0M

Latest News

How The PAVmed (PAVM) Narrative Is Shifting With Reworked Assumptions And A Lower Price Target Simply Wall St. · Jun 1, 2026 PAVmed Inc (PAVM) Q1 2026 Earnings Call Highlights: Strategic Restructuring and Growth ... GuruFocus.com · May 15, 2026 PAVmed (PAVM) Q1 2026 Earnings Transcript Motley Fool · May 15, 2026 PAVmed (PAVM) Q4 2025 Earnings Transcript Motley Fool · May 15, 2026 PAVmed Inc. (PAVM) Reports Q1 Loss, Lags Revenue Estimates Zacks · May 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-41.0M$-71.0M$-52.0M$-34.0M$-5.2B
Investing Cash Flow$-5.0M$-6.0M$1.0M$-16.0M$-31.0M
Financing Cash Flow$2.0M$1.0M$1.0M$0$5.6B
Net Cash Flow$60.0M$-38.0M$-20.0M$-18.0M$353.0M
Free Cash Flow$-42.0M$-73.0M$-52.0M$-34.0M$-5.2B

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-80088.81%
Quick Ratio2.02
Interest Coverage—
Return 1Y-64.51%
Return 3Y-96.52%
Return 5Y-99.73%

Ownership

Insiders Held44.15%
Institutions Held27.52%
Institutions Float Held49.27%
Institutional HolderSharesReport Date
Two Seas Capital Lp461,5392026-03-31
First Manhattan Co. LLC23,8052026-03-31
Geode Capital Management, LLC11,7772026-03-31
Vanguard Capital Management LLC5,9172026-03-31
Vanguard Fiduciary Trust Co5,4292026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADVB $10.13 -29.46% -9.46 $10.96M 0.00%
APVO $4.21 -4.10% -0.06 $9.21M 0.00%
BMRA $1.61 +1.26% -1.09 $4.98M 0.00%
BNRBurning Rock Biotech Limited $11.30 -3.42% -1.36 $11.94M 0.00%
DHAIDIH Holding US, Inc. $0.02 +0.00% 0.00 $41853 0.00%

About PAVM

PAVM is led by CEO Lishan Aklog, employs 39 people, headquartered in US, publicly traded since 2016.

PAVM stock trades at $5.25 with a market capitalization of $2.82M. The stock is valued at a price-to-earnings (P/E) ratio of -1.08, price-to-book of 0.10, price-to-sales of 0.15. Over the past 52 weeks the stock has ranged between $3.85 and $28.44, and currently trades 81.5% below its 52-week high.

On profitability, PAVM generates a return on equity (ROE) of 0.00%, return on capital employed of -100.00%, an operating margin of -364.93%, a net profit margin of -317.57%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides